As shown in Figure 1A, the CASC2 level was significantly decreased in bladder cancer tissues compared with corresponding adjacent non-tumorous tissues (P<0.001, Figure 1A and 1B). This evidence concerns the gene CASC2 and urinary bladder cancer.